Keratosis pilaris-like eruption secondary to nilotinib in a child.
Pediatr Dermatol
; 37(5): 968-969, 2020 Sep.
Article
em En
| MEDLINE
| ID: mdl-32602176
Nilotinib is a new multitargeted tyrosine kinase inhibitor, which is used to treat chronic myelogenous leukemia when intolerance or recurrence to imatinib occurs. We report the case of a 14-year-old patient being treated with nilotinib who developed a keratosis pilaris-like eruption. This cutaneous adverse effect is a rare but increasingly reported side effect of this therapy.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Anormalidades Múltiplas
/
Sobrancelhas
/
Doença de Darier
Limite:
Adolescent
/
Humans
Idioma:
En
Ano de publicação:
2020
Tipo de documento:
Article